Adriaan Kraaijeveld

Adriaan Kraaijeveld

Interventional Cardiologist

UMC Utrecht - Utrecht, Netherlands

  • LinkedIn
  • X
  • Radcliffe

Media

ESC 2018: Rationale For New Treatment Options For Intermediate

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale for New Treatment Options for Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 19m 4s
New Treatment Options For Intermediate-High Risk PE

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 27m 16s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Andrew SP Sharp, Adriaan Kraaijeveld, Nicolas Meneveau, et al

Watch time: 14m 32s
ESC 2018: Acoustic Pulse Thrombolysis™ Treatment For Pulmonary Embolism Patients: Rationale, Experience And Data

Adriaan Kraaijeveld, Nicolas Meneveau, , et al

Watch time: 5m 49s
ESC 2018: Rationale for new treatment options for intermediate-high risk PE patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 19m 4s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 5m 49s
ESC 2018: New Treatment Options - High Risk PE Patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 14m 32s
Symposium at ESC Congress 2018 sponsored by EKOS Corporation

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 5m 49s